Similar articles

• Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens.

  Reddy JK, Azarnoff DL, Hignite CE. Reddy JK, et al. Nature. 1980 Jan 24;283(5745):397-8. doi: 10.1038/283397a0. Nature. 1980. PMID: 6766207 No abstract available.
• Hepatocarcinogenesis of peroxisome proliferators.

  Rao MS, Reddy JK. Rao MS, et al. Ann N Y Acad Sci. 1996 Dec 27;804:573-87. doi: 10.1111/j.1749-6632.1996.tb18646.x. Ann N Y Acad Sci. 1996. PMID: 8993574 Review. No abstract available.
• Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats.

  Tamura H, Iida T, Watanabe T, Suga T. Tamura H, et al. Carcinogenesis. 1990 Mar;11(3):445-50. doi: 10.1093/carcin/11.3.445. Carcinogenesis. 1990. PMID: 2311188
• Species differences in the hepatic response to a potent peroxisome proliferator.

  Makowska JM, Bonner FW, Goldfarb PS, Gibson GG. Makowska JM, et al. Biochem Soc Trans. 1989 Dec;17(6):1072-3. doi: 10.1042/bst0171072. Biochem Soc Trans. 1989. PMID: 2628085 No abstract available.
• An overview of peroxisome proliferator-induced hepatocarcinogenesis.

  Rao MS, Reddy JK. Rao MS, et al. Environ Health Perspect. 1991 Jun;93:205-9. doi: 10.1289/ehp.9193205. Environ Health Perspect. 1991. PMID: 1685443 Free PMC article. Review.